General MedicationsOPHTHALMICStandard
YUVEZZI
BRIMONIDINE TARTRATE; CARBACHOL
Standard Dose
0.1%;2.75%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview YUVEZZI is listed in Drugs@FDA under application 220142 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BRIMONIDINE TARTRATE; CARBACHOL Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.1%;2.75% Sponsor VISUS Submission history Latest submission status date: 2026-01-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview YUVEZZI is listed in Drugs@FDA under application 220142 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BRIMONIDINE TARTRATE; CARBACHOL Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.1%;2.75% Sponsor VISUS Submission history Latest submission status date: 2026-01-28 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.